Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Inspire Medical Systems (INSP) Operating Expenses (2017 - 2025)

Inspire Medical Systems (INSP) has disclosed Operating Expenses for 9 consecutive years, with $186.9 million as the latest value for Q4 2025.

  • Quarterly Operating Expenses rose 8.76% to $186.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $727.8 million through Dec 2025, up 13.06% year-over-year, with the annual reading at $727.8 million for FY2025, 13.06% up from the prior year.
  • Operating Expenses hit $186.9 million in Q4 2025 for Inspire Medical Systems, up from $183.1 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $186.9 million in Q4 2025 to a low of $50.1 million in Q1 2021.
  • Historically, Operating Expenses has averaged $128.5 million across 5 years, with a median of $142.9 million in 2023.
  • Biggest five-year swings in Operating Expenses: surged 75.48% in 2021 and later grew 8.76% in 2025.
  • Year by year, Operating Expenses stood at $69.1 million in 2021, then soared by 68.08% to $116.1 million in 2022, then soared by 33.66% to $155.2 million in 2023, then increased by 10.76% to $171.8 million in 2024, then grew by 8.76% to $186.9 million in 2025.
  • Business Quant data shows Operating Expenses for INSP at $186.9 million in Q4 2025, $183.1 million in Q3 2025, and $185.7 million in Q2 2025.